← Map · Health Care Equipment · S&P 500
HOLX HOLOGIC INC
Taken private Apr 2026 — last public read
What they are doing
Blackstone and TPG completed the take-private on 7 Apr 2026. This is a last public read, not an equity idea. FY2025 10-K: Genius Digital Diagnostics with the Genius Cervical AI Algorithm (FDA De Novo DEN210035, Jan 2024), Genius AI Detection 2.0 (K243341, Jul 2025), and 3DQuorum (claimed ~1 hour saved per 8 hours of reading — a labeled spec, not a 2026 operating KPI). Last 10-Q is Dec 2025; no Q2 2026 call. Do not put this on the interesting-ones list as a position.
Why the score
- Reach 3 not 4: cervical cytology + breast CAD / 3DQuorum. Not the whole chain.
- Weight 3 not 4: AI is in the diagnostic offer. Still a hardware / assay company.
- Proof 3 not 4: FDA-cleared, named in the 10-K. No current public KPI.
What would move it next quarter: Off the public list. Keep the score as a last print only.
Open these first
Evidence
Genius Digital Diagnostics with the Genius Cervical AI Algorithm: first CE-marked and FDA-cleared digital cytology platform. Genius AI Detection, including PRO. 3DQuorum: AI-powered algorithm that reduces 3D images to review by two-thirds, saving an estimated average of one hour per eight hours of daily image interpretation — labeled spec, not a 2026 operating series.
Last public 10-Q. Repeats 10-K AI product language. No new algorithm KPI. No later 10-Q — company private 7 Apr 2026.
Blackstone and TPG completed the acquisition. Nasdaq listing ended 7 Apr 2026.